{"doi":"10.7326/0003-4819-138-4-200302180-00014","title":"Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy","abstract":null,"journal":"Annals of Internal Medicine","year":2003,"id":14163,"datarank":20.192414806768767,"base_score":6.643789733147672,"endowment":6.643789733147672,"self_citation_contribution":0.996568459972151,"citation_network_contribution":19.195846346796614,"self_endowment_contribution":0.996568459972151,"citer_contribution":19.195846346796614,"corpus_percentile":null,"corpus_rank":null,"citation_count":767,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":4,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":113110,"name":"Roscoe Brady","orcid":null,"position":1,"is_corresponding":false},{"id":113111,"name":"John Barranger","orcid":null,"position":2,"is_corresponding":false},{"id":113112,"name":"Allan J. Collins","orcid":null,"position":3,"is_corresponding":false},{"id":113113,"name":"Dominique P. Germain","orcid":null,"position":4,"is_corresponding":false},{"id":113114,"name":"Martin Goldman","orcid":null,"position":5,"is_corresponding":false},{"id":113115,"name":"Gregory Grabowski","orcid":null,"position":6,"is_corresponding":false},{"id":113116,"name":"Seymour Packman","orcid":null,"position":7,"is_corresponding":false},{"id":113117,"name":"William R. Wilcox","orcid":null,"position":8,"is_corresponding":false},{"id":113109,"name":"Robert J. Desnick","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":6.643789733147672,"endowment":6.643789733147672,"datacite_reuse_total":4,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"12585833","pmcid":null,"openalex_id":"https://openalex.org/W2043774580","authors":[],"funders":[{"funder_name":"NIDDK NIH HHS","grant_id":"5 R37 DK34045","title":null}],"total_grants":1,"fwci":19.6246,"citation_percentile":0.99717514,"influential_citations":28,"citation_trend":[{"year":2012,"count":42},{"year":2013,"count":25},{"year":2014,"count":40},{"year":2015,"count":17},{"year":2016,"count":32},{"year":2017,"count":32},{"year":2018,"count":27},{"year":2019,"count":25},{"year":2020,"count":39},{"year":2021,"count":28},{"year":2022,"count":35},{"year":2023,"count":40},{"year":2024,"count":36},{"year":2025,"count":21},{"year":2026,"count":3}],"oa_status":"closed","license":"https://www.acpjournals.org/journal/aim/text-and-data-mining","oa_locations":[{"url":"http://annals.org/data/journals/aim/20028/0000605-200302180-00014.pdf","host_type":"BRONZE"},{"url":"https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-138-4-200302180-00014","host_type":"publisher"},{"url":"https://www.acpjournals.org/doi/full-xml/10.7326/0003-4819-138-4-200302180-00014","host_type":"publisher"},{"url":"https://doi.org/10.7326/0003-4819-138-4-200302180-00014","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/12585833","host_type":"repository"}],"fields_of_study":["Lysosomal Storage Disorders Research","Carbohydrate Chemistry and Synthesis","Glycogen Storage Diseases and Myoclonus","Medicine","Clinical Protocols","Clinical Trials as Topic","Disease Progression","Expert Testimony","Fabry Disease","Female","Heterozygote","Humans","Male","Recombinant Proteins","alpha-Galactosidase"],"mesh_terms":["alpha-Galactosidase","Fabry Disease","Clinical Protocols","Clinical Trials as Topic","Expert Testimony","Female","Heterozygote","Humans","Male","Recombinant Proteins","Disease Progression"],"keywords":["Medicine","Enzyme replacement therapy","Fabry disease","Disease","Intensive care medicine","Disease management","Pediatrics","Pathology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.24091765.v1","title":"Additional file 1 of Systematic gene therapy derived from an investigative study of AAV2/8 vector gene therapy for Fabry disease","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.24091765","title":"Additional file 1 of Systematic gene therapy derived from an investigative study of AAV2/8 vector gene therapy for Fabry disease","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.24987767.v1","title":"Additional file 1 of Fabry App: the value of a portable technology in recording day-to-day patient monitored information in patients with Fabry disease","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.24987767","title":"Additional file 1 of Fabry App: the value of a portable technology in recording day-to-day patient monitored information in patients with Fabry disease","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-01T05:16:59.023503Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}